196 related articles for article (PubMed ID: 31944219)
1. Analysis of Price Transparency via National Cancer Institute-Designated Cancer Centers' Chargemasters for Prostate Cancer Radiation Therapy.
Agarwal A; Dayal A; Kircher SM; Chen RC; Royce TJ
JAMA Oncol; 2020 Mar; 6(3):409-412. PubMed ID: 31944219
[TBL] [Abstract][Full Text] [Related]
2. Price transparency implementation: Accessibility of hospital chargemasters and variation in hospital pricing after CMS mandate.
Lu AJ; Chen EM; Vutam E; Brandt J; Sadda P
Healthc (Amst); 2020 Sep; 8(3):100443. PubMed ID: 32919582
[TBL] [Abstract][Full Text] [Related]
3. Large Variations in the Prices of Urologic Procedures at Academic Medical Centers 1 Year After Implementation of the Price Transparency Final Rule.
Gul ZG; Sharbaugh DR; Guercio CJ; Pelzman DL; Jones CA; Hacker EC; Anyaeche VI; Bowers L; Shah AM; Stencel MG; Yabes JG; Jacobs BL; Davies BJ
JAMA Netw Open; 2023 Jan; 6(1):e2249581. PubMed ID: 36602800
[TBL] [Abstract][Full Text] [Related]
4. Health Care Price Transparency in Ophthalmology.
Berkowitz ST; Siktberg J; Hamdan SA; Triana AJ; Patel SN
JAMA Ophthalmol; 2021 Nov; 139(11):1210-1216. PubMed ID: 34617970
[TBL] [Abstract][Full Text] [Related]
5. Less Than One-third of Hospitals Provide Compliant Price Transparency Information for Total Joint Arthroplasty Procedures.
Burkhart RJ; Hecht CJ; Acuña AJ; Kamath AF
Clin Orthop Relat Res; 2022 Dec; 480(12):2316-2326. PubMed ID: 35901439
[TBL] [Abstract][Full Text] [Related]
6. Cost Comparison From a Patient Perspective for Intracranial Stereotactic Radiation Therapy.
Prasad RN; Yildiz VO; Patel T; Royce TJ; Palmer JD
Adv Radiat Oncol; 2022; 7(1):100816. PubMed ID: 35071832
[TBL] [Abstract][Full Text] [Related]
7. Variability in expenses related to spine oncology care: comparison of payer-negotiated rates at National Cancer Institute-Designated Cancer Centers.
Kasthuri VS; Alsoof D; Balmaceno-Criss M; Daher M; McDonald CL; Diebo BG; Kuris EO; Daniels AH
Spine J; 2024 Feb; 24(2):304-309. PubMed ID: 38440969
[TBL] [Abstract][Full Text] [Related]
8. Survey of Hospital Chargemaster Transparency.
Arvisais-Anhalt S; McDonald S; Park JY; Kapinos K; Lehmann CU; Basit M
Appl Clin Inform; 2021 Mar; 12(2):391-398. PubMed ID: 33951742
[TBL] [Abstract][Full Text] [Related]
9. List Prices for Proton Radiation Therapy.
Prasad RN; Patel T; Perlow HK; Yildiz VO; Baliga S; Brownstein J; Gamez ME; Konieczkowski DJ; Royce TJ; Palmer JD
Pract Radiat Oncol; 2022; 12(3):e163-e168. PubMed ID: 35512990
[TBL] [Abstract][Full Text] [Related]
10. The Price-Quality Mismatch: Are Negotiated Prices for Total Joint Arthroplasty Associated With Hospital Quality in a Large California Health System?
Zhuang T; Shapiro LM; Baker LC; Kamal RN
Clin Orthop Relat Res; 2023 Jun; 481(6):1061-1068. PubMed ID: 36729581
[TBL] [Abstract][Full Text] [Related]
11. Investigation of Hospital Pricing Information for Plastic Surgery Procedures Reveals Widespread Violation of the CMS Price Transparency Act.
Askinas C; Shih S; Puyana S; Chaffin AE; Jansen DA
Plast Reconstr Surg; 2023 Aug; 152(2):455-462. PubMed ID: 36790781
[TBL] [Abstract][Full Text] [Related]
12. Not Clearing the Air: Hospital Price Transparency for a Laparoscopic Cholecystectomy.
Green RL; Dunham P; Kling SM; Kuo LE
J Surg Res; 2022 Dec; 280():501-509. PubMed ID: 36081309
[TBL] [Abstract][Full Text] [Related]
13. Hospital-Administered Cancer Therapy Prices for Patients With Private Health Insurance.
Xiao R; Ross JS; Gross CP; Dusetzina SB; McWilliams JM; Sethi RKV; Rathi VK
JAMA Intern Med; 2022 Jun; 182(6):603-611. PubMed ID: 35435948
[TBL] [Abstract][Full Text] [Related]
14. Evaluating hospital consumer-friendly price-estimator tools for shoppable services within dermatology.
Yang K; Drake L; Ghatnekar S; Kassamali B; Nambudiri VE
Arch Dermatol Res; 2023 Aug; 315(6):1813-1821. PubMed ID: 36705758
[TBL] [Abstract][Full Text] [Related]
15. Provision of Hospital Price Information After Increases in Financial Penalties for Failure to Comply With a US Federal Hospital Price Transparency Rule.
Kong E; Ji Y
JAMA Netw Open; 2023 Jun; 6(6):e2320694. PubMed ID: 37378982
[TBL] [Abstract][Full Text] [Related]
16. Increasing Divergence in Drug Prices Between the United States and Germany After Implementation of Comparative Effectiveness Analysis and Collective Price Negotiations.
Berkemeier F; Whaley C; Robinson JC
J Manag Care Spec Pharm; 2019 Dec; 25(12):1310-1317. PubMed ID: 31778624
[TBL] [Abstract][Full Text] [Related]
17. Price transparency of prostate cancer care in the United States: An analysis of pricing and disclosure following the centers for medicare and medicaid mandate.
Brant A; Lewicki P; Rhodes S; Arenas-Gallo C; Strasser MO; Zhu A; Ponsky L; Shoag JE
Prostate Cancer Prostatic Dis; 2024 Jun; 27(2):252-256. PubMed ID: 36717642
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Hospital Compliance With Federal Price Transparency Regulations and Variability of Negotiated Rates for Spinal Fusion.
Issa TZ; Lee Y; Mazmudar AS; Padovano R; Lambrechts MJ; Canseco JA; Hilibrand AS; Vaccaro AR; Kepler CK; Schroeder GD
J Am Acad Orthop Surg; 2023 Jul; 31(13):677-686. PubMed ID: 37015104
[TBL] [Abstract][Full Text] [Related]
19. A Radiology-focused Analysis of Transparency and Usability of Top U.S. Hospitals' Chargemasters.
Glover M; Whorms D; Singh R; Almeida RR; Prabhakar AM; Saini S; Rosenkrantz AB
Acad Radiol; 2020 Nov; 27(11):1603-1607. PubMed ID: 32014405
[TBL] [Abstract][Full Text] [Related]
20. Compliance and Variability of Hospital Price Transparency in Total Knee and Hip Arthroplasty in the United States.
Bhayana K; Ghodasra JH; Sanghavi KK; Aliu O; Giladi AM
J Am Acad Orthop Surg; 2022 Jun; 30(12):e886-e893. PubMed ID: 35294420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
